MADIT II (second Multicenter Automated Defibrillator Implantation Trial) debate: risk stratification, costs, and public policy

MR Reynolds, ME Josephson - Circulation, 2003 - Am Heart Assoc
It turns out that 78% of the MADIT II patients randomized to the ICD arm had EP studies done
in conjunction with their ICD implants, most apparently by standard catheter techniques. 10 …

Outcome of advisory implantable cardioverter-defibrillator replacement: one-year follow-up

PA Gould, LJ Gula, J Champagne, JS Healey… - Heart Rhythm, 2008 - Elsevier
BACKGROUND: Implantable cardioverter defibrillator (ICD) generator advisories present
management dilemmas for physicians regarding competing risks of ICD failure and …

Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the …

BL Wilkoff, BD Williamson, RS Stern, SL Moore… - Journal of the American …, 2008 - jacc.org
Objectives: Our purpose was to demonstrate that strategically chosen implantable
cardioverter-defibrillator (ICD) ventricular tachycardia (VT) or ventricular fibrillation (VF) …

Development and external validation of prediction models to predict implantable cardioverter-defibrillator efficacy in primary prevention of sudden cardiac death

TE Verstraelen, M Van Barreveld… - EP …, 2021 - academic.oup.com
Aims This study was performed to develop and externally validate prediction models for
appropriate implantable cardioverter-defibrillator (ICD) shock and mortality to identify …

Patients' attitudes and perceptions of implantable cardioverter‐defibrillators: potential barriers to appropriate primary prophylaxis

J Yuhas, K Mattocks, L Gravelin… - Pacing and clinical …, 2012 - Wiley Online Library
Background: Primary prophylaxis with implantable cardioverter‐defibrillators (ICDs)
improves mortality in patients at risk for sudden cardiac death (SCD). However, ICDs are …

[图书][B] Implantable Cardioverter-Defibrillators Step by Step: An Illustrated Guide

RX Stroobandt, SS Barold, AF Sinnaeve - 2011 - books.google.com
Implantable Cardioverter-Defibrillators Step by Step Implantable Cardioverter-Defibrillators
Step by Step AN ILLUSTRATED GUIDE Health care professionals now have a clear and …

How to manage the patient with a high defibrillation threshold

SK Mainigi, DJ Callans - Heart Rhythm, 2006 - Elsevier
Defibrillation threshold (DFT) testing is an integral part of implantable cardioverter-
defibrillator (ICD) placement and follow-up. Unfortunately, the DFT can vary widely from day …

Consensus statement on indications, guidelines for use, and recommendations for follow-up of implantable cardioverter defibrillators.

SL Winters, DL Packer, FE Marchlinski… - Pacing & Clinical …, 2001 - search.ebscohost.com
Features the consensus statement issued by the North American Society of
Electrophysiology and Pacing, in conjunction with the American College of Cardiology …

Accf/hrs/aha/ase/hfsa/scai/scct/scmr 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: A report of the …

AM Russo, RF Stainback, SR Bailey, AE Epstein… - Journal of the American …, 2013 - jacc.org
Abstract The American College of Cardiology Foundation in collaboration with the Heart
Rhythm Society and key specialty and subspecialty societies conducted a review of common …

The role of implantable cardioverter-defibrillators and sudden cardiac death prevention: indications, device selection, and outcome

I Goldenberg, DT Huang, JC Nielsen - European heart journal, 2020 - academic.oup.com
Multiple randomized multicentre clinical trials have established the role of the implantable
cardioverter-defibrillator (ICD) as the mainstay in the treatment of ventricular …